Physician profile
Brooke Kovacic
NPI 1881234839
$1,317.84
in general payments reported to CMS, 2019-2025
13 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $534 · 2022: $413 · 2023: $176 · 2024: $13.25 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $375.28 | 2022-2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Medtronic, INC. | $184.84 | 2022 | |
| Biom'Up France Sas | $150.54 | 2021 | |
| La Jolla Pharmaceutical Company | $122.28 | 2023 | Giapreza |
| Baxter Healthcare | $116.55 | 2021 | |
| Zimmer Biomet Holdings, INC. | $105.15 | 2021 | |
| Saphena Medical, INC. | $100.61 | 2021 | |
| Edwards Lifesciences Corporation | $52.12 | 2021-2022 | |
| Haemonetics Corporation | $40.01 | 2025 | Teg6s Hemostasis System |
| Ethicon US, LLC | $24.12 | 2021 | |
| Abiomed | $20.13 | 2025 | |
| Getinge USA Sales, LLC | $13.25 | 2024 | Vasoview Hemopro 2 |
| Janssen Pharmaceuticals, INC | $12.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Kovacic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.